JBI-802
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JBI-802, covering 2023-06-15 to 2025-10-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation. [Phase 2]